NASDAQ Companies

–   60% response rate observed among 10 evaluable patients –   Favorable safety profile in 26 patients enrolled as of the […]

MCLA-145 monotherapy and in combination with pembrolizumab rapid oral session presentation: June 2, 2024, 11:30 a.m.-1:00 p.m. CT MCLA-129 in […]

ARTISTRY-3 trial is being conducted to evaluate less frequent dosing of nemvaleukin alfa, Mural’s late-stage lead candidate Nemvaleukin demonstrated pharmacodynamic […]

Abstract released today highlights safety, pharmacodynamic and clinical response data with additional data to be presented in a poster session […]

BEIJING, May 23, 2024 (GLOBE NEWSWIRE) — JD.com, Inc. (“JD” or the “Company”) (NASDAQ: JD and HKEX: 9618 (HKD counter) […]

NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) — Verita CSG, Inc. (Verita), a visionary Managing General Underwriting (MGU) company, today […]

 Adjourns Special Meeting to May 31, 2024 in order to Solicit Additional Proxies in Support of its Plan of Liquidation […]

ATLANTA, GA, May 23, 2024 (GLOBE NEWSWIRE) — Trust Stamp (Nasdaq: IDAI), the AI-powered, Privacy First Identity CompanyTM announces that […]

Enter for a Chance to Win Iconic Burger Pool Accessory and Land $5 Off a PEPSI Float with Burger Purchase […]

Atlanta, GA, May 23, 2024 (GLOBE NEWSWIRE) — Trust Stamp (Nasdaq: IDAI), the AI-powered, Privacy First Identity CompanyTM announces that […]